MENU
EVO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Evotec SE (EVO) Ownership - Who owns Evotec SE?
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations... Show more
Profile
Industry
N/A
Address
Essener Bogen 7
Phone
+49 40560810
Employees
4952
Web
https://www.evotec.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
2.77B
P/E Ratio
476.19
Total Cash
619.18M
Projected Growth
N/A
Total Debt
588.74M
Revenue
820.8M
Risk (Beta)
1.80
Dividend Yield
N/A
Total Cash/Share
1.75
Total Debt/Equity
N/A
Revenue/Share
2.51 USD as % of share price
Fundamentals
EVO
Capitalization
2.77B
P/E Ratio
476.19
Risk (Beta)
1.80
Dividend Yield
N/A
Total Cash
619M
Total Cash/Share
1.75
Total Debt
589M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.51%
Revenue
821M
ROE
N/A
Book Value
1.14B
P/B Ratio
2.22
Cash Flow
N/A
Earnings
-0.26
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
177M
Current Ratio
2.16
Current Revenue Per Employee
38591.82
Dividends Per Share - Security
N/A
EBITDA
-63.26M
Float
N/A
Float - Current
N/A
Gross Income Margin
19.27
Revenue To Assets
-4.21
Shares Held By Institutions
81.9M
Shares Outstanding - Current
354M
Total Liabilities
1.11B
Total Volume MTD
N/A
Value
-1
Gain YTD
-22.356
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry PharmaceuticalsOther
Profile
Fundamentals
Details
Industry
N/A
Address
Essener Bogen 7
Phone
+49 40560810
Employees
4952
Web
https://www.evotec.com